- Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy
Burak Arslan et al, 2017, Tumori Journal CrossRef - Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound‑guided needle biopsy specimens of prostate adenocarcinoma
Jagtar Singh et al, 2021, Molecular and Clinical Oncology CrossRef - Assessing the diagnostic impact of P63, PSA and BCL-2 proteins in premalignant and malignant prostate tissues
Aderonke C. Ogunlayi et al, 2024, International Journal of Scientific Reports CrossRef - IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute
Paul Katongole et al, 2022, Future Oncology CrossRef - Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features
Catarina Ferreira et al, 2018, Virchows Archiv CrossRef - Distinctive expression and cellular localisation of zinc homeostasis-related proteins in breast and prostate cancer cells
Shital K. Barman et al, 2024, Journal of Trace Elements in Medicine and Biology CrossRef - An insight into the complex roles of metallothioneins in malignant diseases with emphasis on (sub)isoforms/isoforms and epigenetics phenomena
Sona Krizkova et al, 2018, Pharmacology & Therapeutics CrossRef - Identification of a Robust Five-Gene Risk Model in Prostate Cancer: A Robust Likelihood-Based Survival Analysis
Yutao Wang et al, 2020, International Journal of Genomics CrossRef - Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
Xi Liu et al, 2022, Cancer Cell International CrossRef